Search
for
Sort by
Research 30 of 1000+
- Early Antiandrogen Therapy With Dutasteride Reduces Viral Shedding, Inflammatory Responses, and Time-to-Remission in Males With COVID-19: A Randomized, Double-Blind, Placebo-Controlled Interventional Trial (EAT-DUTA AndroCoV Trial – Biochemical)
- Pathological sequelae of long-haul COVID
- Pattern changes of cutaneous dermatoses among Iraqi women preceding and during the COVID-19 pandemic
- EFFECT OF POTASSIUM ON BLOOD-SUGAR AND PLASMA-INSULIN LEVELS IN PATIENTS UNDERGOING PERITONEAL DIALYSIS AND HÆMODIALYSIS
- A 6‐Month Open‐Label Clinical Study Evaluating Hair and Skin Parameters After Daily Intake of a Multifactorial Drinkable Nutraceutical in Menopausal and Postmenopausal Women With Female Pattern Hair Loss
- The Need to Analyze Telogen Effluvium and Alopecia Areata Parallelly in Long COVID Studies
- Eflúvio telógeno pós-infecção por Covid-19: uma revisão narrativa / Telogen effluvium post Covid-19 infection: a narrative review
- Apoptosis and cutaneous biology
- Early COVID-19 Therapy with Azithromycin Plus Nitazoxanide, Ivermectin or Hydroxychloroquine in Outpatient Settings Significantly Reduced Symptoms Compared to Known Outcomes in Untreated Patients
- Azithromycin with nitazoxanide, hydroxychloroquine or ivermectin, with or without dutasteride, for early stage COVID-19: an open-label prospective observational study in males with mild-to-moderate COVID-19 (The Pre-AndroCoV Male Trial).
- The impact of SARS-CoV-2 and COVID-19 on male reproduction and men’s health
- Role of testosterone in SARS-CoV-2 infection: A key pathogenic factor and a biomarker for severe pneumonia
- Early COVID-19 Therapy with Azithromycin Plus Nitazoxanide, Ivermectin or Hydroxychloroquine in Outpatient Settings Significantly Reduced Symptoms Compared to Known Outcomes in Untreated Patients.
- Azithromycin with nitazoxanide, hydroxychloroquine or ivermectin, with or without dutasteride, for early stage COVID-19: an open-label prospective observational study in males with mild-to-moderate COVID-19 (The Pre-AndroCoV Male Trial).
- COVID-19 and androgenic status: testosterone or dihydrotestosterone have a pivotal role?
- Analyzing The Ebola ViruAnalyzing The Impact That The Ebola Virus Disease Has on Children
- Low‐dose oral minoxidil improves global hair density and length in children with loose anagen hair syndrome
- A Clinical Study to Evaluate Effectiveness of Rosmarinus officinalis Mother Tincture in Improving Hair Volume and Density in Patients with Diffuse Cyclical Hair Loss Through Hair Shedding Visual Scale and Ponytail Thickness Test
- Sexual dimorphism of COVID-19 inspires drug repositioning and host-targeting immunotherapy for viral pneumonia
- What can the hair tell us about COVID‐19?
- Dermatological manifestations associated with COVID‐19: A comprehensive review of the current knowledge
- Telogen effluvium: a sequela of COVID‐19
- Is there a role for dermatologists in eating disorders?
- Clinical Evaluation of Standardized Bhringaraj (Eclipta alba) Extract Tablets in Hair Fall: A 24 Week Prospective Trial
- TREATMENT OF DIFFUSE HAIR FALL (INTITHĀR AL-SHA'R) THROUGH UNANI MEDICINE: A CASE STUDY
- Methodological Considerations for Hair Cortisol Analysis: Effects of Resuspension Solution, Hair Weight, Extraction Duration, and Degree of Hair Shredding on Hair Cortisol Concentrations
- Viable SARS-CoV-2 shedding under remdesivir and dexamethasone treatment
- SARS‐CoV‐2‐induced telogen effluvium: a multicentric study
- CLINICAL AND LABORATORY EVALUATION OF AIDS TRICHOPATHY
- The probable destructive mechanisms behind COVID-19 on male reproduction system and fertility